irSQUOHC_708x531

Storage

Taking a chilled approach to storage

Eramol’s clients set great store by our ability to offer State-of-the-Art clinical storage, retaining their goods with us in optimal conditions throughout the product’s lifecycle.

Once a drug has been developed, it needs to be kept in perfect conditions prior to shipment. Our in-house logistics specialists ensure that no matter how long you need us to hold your goods, products remain stable, prior to distribution.

Eramol currently serves as the UK, EU and Global IMP distribution hub for several international clients. We boast storage and distribution facilities providing controlled ambient, cold chain and frozen storage areas with temperature ranges that include: 15-25°C, 2-8°C -20°C, and -80°C. Our service supports:

  • IVRS/IWRS support and integration;
  • Fully owned GMP certified storage depots in UK & Ireland
  • Local storage depots via approved Eramol partners in Austria, Spain, Australia, Brazil, USA and Canada offering additional global distribution options
  • A wide range of approved couriers provide same day, direct, next day and cold chain shipments
  • Validated temperature shipper containers
  • The management of all IMP returns and destruction
  • A 24/7 emergency logistics contact to all clients in order to manage any unexpected distribution issues during the study.

Direct-to-patient supply and the management of controlled narcotics/substances

Eramol has an approved courier who manages all direct-to-patient supplies across the UK and EU. We are also authorised for controlled drug and narcotic storage and distribution, including the handling of Schedule 1 – 5 controlled substances.

Additionally, we manage importation and exportation licenses and have considerable experience in the importation, exportation and storage of medical cannabis (THC/CBD) and hallucinogenic products.

Our Other Services

Sterile Manufacturing

Eramol delivers a purpose-built, EU GMP Annex 1–compliant sterile manufacturing service dedicated to Phase I and Phase II clinical trial supply. Our facility is designed for agility, reliability, and regulatory strength by integrating advanced isolator technology, closed-system processing, moist heat terminal sterilisation and a full end-to-end clinical supply chain — ensuring your sterile injectable, cartridges and pre filled syringes reach patients safely, on time and in full regulatory compliance.

Non Sterile Manufacturing

GMP Production of Tablets, Capsules & Oral Liquids for Phase I–III and Commercial Supply Eramol delivers end-to-end non-sterile manufacturing built on a foundation of quality, regulatory expertise, and Qualified Person (QP) leadership. Our Sevenoaks GMP facility, commissioned in November 2021 and operational since August 2022, supports the full product lifecycle—from early-phase clinical development right through to commercial supply.

Labelling Solutions

Our versatile and extensive labelling solutions have been designed to offer flexibility, economy of scale and to meet the demands of last-minute requirements.

Reliable. Proven. Safe. Effective.

Reliable. Proven. Safe. Effective.

Speak With Us

Products on online services or over the Internet. Electronic commerce draws on
technologies such as mobile commerce application

Scroll to Top